Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | BCHE | P06276 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | HBB | P68871 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL7371392 | 0.97 | TSHR (0.45) | TSHRTDP1ALDH1A1LMNAHRH3 | |
| SCHEMBL6948121 | 0.92 | TSHR (0.48) | TSHRTDP1ALDH1A1LMNAHRH3 | |
| SCHEMBL14395271 | 0.90 | TSHR (0.55) | TSHRTDP1ALDH1A1 | |
| SCHEMBL6942252 | 0.89 | TSHR (0.52) | TSHRTDP1ALDH1A1LMNAHRH3 | |
| SCHEMBL11872473 | 0.89 | TSHR (0.52) | TSHRTDP1ALDH1A1LMNAHRH3 | |
| SCHEMBL12334526 | 0.89 | TSHR (0.43) | TSHRTDP1ALDH1A1HRH3 | |
| SCHEMBL282416 | 0.88 | TSHR (0.56) | TSHRTDP1ALDH1A1LMNAMAPT | |
| Hydrochloric Acid SCHEMBL6139434 | 0.86 | TSHR (0.53) | TSHRTDP1ALDH1A1LMNAMAPT | |
| SCHEMBL11835178 | 0.86 | TSHR (0.53) | TSHRTDP1ALDH1A1LMNAMAPT | |
| SCHEMBL7681688 | 0.86 | TSHR (0.55) | TSHRTDP1ALDH1A1LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110167977-B | Conjugated diene polymer, conjugated diene polymer composition, and tire | 日本弹性体株式会社 | 2021-11-16 | — | — | CN | disclosed |
| CN-109476778-B | Modified conjugated diene polymer, modified conjugated diene polymer composition, tire, and method for producing modified conjugated diene polymer | 日本弹性体株式会社 | 2021-05-11 | — | — | CN | disclosed |
| CN-107250172-B | Modified conjugated diene polymer, method for producing same, and modified conjugated diene polymer composition | 旭化成株式会社 | 2021-04-09 | — | — | CN | disclosed |
| US-6642231-B2 | Antineoplastic agents, treatment for neuronal injury and degeneration | AVENTIS PHARMACEUTICALS INC. | 2003-11-04 | — | — | US | disclosed |
| EP-1056744-B1 | 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | AVENTIS PHARMA INC (US) | 2003-10-22 | — | — | EP | disclosed |
| EP-0928809-B1 | POLYSACCHARIDE DERIVATIVE/MAGNETIC METAL OXIDE COMPOSITE | MEITO SANGYO KK (JP) | 2003-10-22 | — | — | EP | disclosed |
| US-20030105098-A1 | 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines | AVENTISUB II INC. | 2003-06-05 | — | — | US | disclosed |
| US-6479487-B1 | INHIBIT CYCLIN DEPENDENT KINASES, PARTICULARLY CDK-2; ANTIAPOPTOSIS AGENT; INHIBITS DEVELOPMENT OF NEOPLASMS | AVENTIS PHARMACEUTICALS INC. | 2002-11-12 | — | — | US | disclosed |
| US-6165378-A | Polysaccharide derivative/magnetic metal oxide composite | MEITO SANGYO KABUSHIKI KAISHA (JP) | 2000-12-26 | — | — | US | disclosed |
| EP-1056744-A1 | 6,9-DISUBSTITUTED 2- TRANS-(4- AMINOCYCLOHEXYL) AMINO]PURINES | Aventis Pharmaceuticals Inc. (US) | 2000-12-06 | — | — | EP | disclosed |
| EP-0114410-B1 | SUBSTITUTED ALPHA-(ETHYL)-ALPHA-(PHENYL)-(OMEGA-(DIALKYLAMINO)-ALKOXY)-BENZYL ALCOHOLS, THEIR ACID ADDITION SALTS AND QUATERNARY SALTS, PROCESS FOR THEIR PREPARATION, AS WELL AS MEDICINES CONTAINING THESE COMPOUNDS | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1986-05-14 | — | — | EP | disclosed |
| EP-0179492-A2 | Heat-sensitive recording material | KANZAKI PAPER MANUFACTURING COMPANY LIMITED (JP) | 1986-04-30 | — | — | EP | disclosed |
| EP-0114410-A1 | Substituted alpha-(ethyl)-alpha-(phenyl)-(omega-(dialkylamino)-alkoxy)-benzyl alcohols, their acid addition salts and quaternary salts, process for their preparation, as well as medicines containing these compounds | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1984-08-01 | — | — | EP | disclosed |
| US-4117128-A | SULFONYL BENZOFURANS AND BENZOTHIOPHENES HAVING CORONARY VASODILATOR ACTIVITY | SMITHKLINE CORPORATION (US) | 1978-09-26 | — | — | US | disclosed |
| US-4075202-A | S-TRIAZOLO-1,5-BENZODIAZPINE-4-ONES | THE UPJOHN COMPANY (US) | 1978-02-21 | — | — | US | disclosed |
| US-4048322-A | Bronchially effective xanthene-9-carboxylates | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1977-09-13 | — | — | US | disclosed |
| US-4044146-A | CHOLINOLYTIC, BRONCHOSPASMOLYTIC | RICHTER GEDEON VEGYESZETI GYAR R.T. (HU) | 1977-08-23 | — | — | US | disclosed |
| US-4024273-A | Coronary vasodilator and anti-anginal compositions comprising substituted benzofurans and benzothiophenes and methods of producing coronary vasodilation and anti-anginal activity | SMITHKLINE CORPORATION (US) | 1977-05-17 | — | — | US | disclosed |
| US-4021557-A | BRONCHOSPASMOLYTICS | BOEHRINGER INGELHEIM GMBH (DT) | 1977-05-03 | — | — | US | disclosed |
| US-3947470-A | CORONARY VASODILATORS, TREATMENT OF ANGINA PECTORIS | SMITHKLINE CORPORATION (US) | 1976-03-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030105098-A1 | 6,9-disubstituted 2-[trans-(4-aminocyclohexyl) amino] purines | CDK6, CDK5, CDK2 | TSHR 4411/4885TDP1 210/4885ALDH1A1 2147/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.